Screener
Guardant Health GH Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Guardant Health in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The source filing: Guardant Health’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001576280-26-000026
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of property and equipment | (5,580) | (4,459) |
| Net cash provided by investing activities | $699,418 | $302,864 |
| FINANCING ACTIVITIES: | ||
| Proceeds from issuance of common stock upon exercise of stock options | $3,651 | $768 |
| Employee taxes paid related to net share settlement of restricted stock units | (20,650) | (15,497) |
| Repurchase of treasury stock | — | (45,010) |
| Payment of debt issuance costs | (102) | (12,138) |
| Proceeds from unwinding of convertible note hedges | — | 5,030 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Guardant Health's stock issuance proceeds?
- Guardant Health (GH) reported stock issuance proceeds of $3.65M in Q1 2026.
- How has Guardant Health's stock issuance proceeds changed year-over-year?
- Guardant Health's stock issuance proceeds increased by 375.4% year-over-year, from $768K to $3.65M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Guardant Health's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude